Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, Chief Operating Officer of Vector BioMed, shares how the company is reimagining viral vec...

April 25, 2025 | Friday | Interview
Sanofi CEO Paul Hudson Confident in 2025 Growth Trajectory as Q1 Sales Climb 9.7% and Pipeline Delivers Six Approvals

CEO Paul Hudson: Confidence in Full-Year Outlook Paul Hudson, Chief Executive Officer: “We had a strong start in 2025 with sales growth of 9.7%, b...

April 24, 2025 | Thursday | Company results
John Rim Drives Samsung Biologics to KRW 1.3 Trillion Q1 Revenue as Plant 5 and ADC Facility Fuel Global CDMO Expansion

- Recorded Q1’25 consolidated revenue of KRW 1.3 trillion - Recorded Q1’25 consolidated operating profit of KRW 486.7 billion - Company exp...

April 24, 2025 | Thursday | Company results
Marc N. Casper Steers Thermo Fisher to Strong Q1 Results with $10.36 Billion Revenue and 15% EPS Growth, Defying Economic Headwinds

  First quarter revenue was $10.36 billion. First quarter GAAP diluted earnings per share (EPS) grew 15% to $3.98. First quarter adjusted EPS gre...

April 24, 2025 | Thursday | Company results
Precision Medicine in Asia: From Genomics to Oncology Impact

    As Asia accounts for nearly half of the world’s cancer burden, the push toward precision medicine is more critical than ever. In this...

April 11, 2025 | Friday | Interview
BIO CEO John F. Crowley Warns of Lasting Damage if Pharma Tariffs Move Forward

  Will Tariffs Hit Pharmaceuticals? The Calm Before the Storm While the pharmaceutical industry may have narrowly escaped the latest wave of U.S. ta...

April 08, 2025 | Tuesday | News
Croda Strengthens Executive Team with Appointment of Stephen Oxley as CFO and Dr. Thomas Riermeier as President of Life Sciences

Croda is pleased to announce the appointments of Stephen Oxley as Chief Financial Officer (CFO) and Executive Director, and Dr. Thomas Riermeier as Presi...

April 01, 2025 | Tuesday | News
WuXi Biologics CEO Dr. Chris Chen Projects Accelerated Growth in 2025 After Solid 2024 Performance

WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025   Revenue grew 9.6% YoY to RMB 18,675.4 million, with ...

March 26, 2025 | Wednesday | Company results
Aragen Strengthens Leadership with Key Appointments in Drug Discovery and Chemical Development

Aragen, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced two senior level appointments. Dr. Manjunath Rama...

March 10, 2025 | Monday | News
Belén Garijo Leads Merck Back to Profitable Growth, Delivering Strong 2024 Performance

  Key Financial Highlights: Full-year net sales increased to €21.2 billion (organically: +2.0%) EBITDA pre rose to €6.1 billion (orga...

March 06, 2025 | Thursday | Company results
Emergent BioSolutions CEO Joe Papa Reports Strong Adjusted EBITDA Growth in 2024, Forecasts Continued Profitability in 2025

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million, de...

March 04, 2025 | Tuesday | Company results
Merck KGaA Ushers in New Leadership Era with Key Executive Appointments

Appointment of three internal senior executives ensures strategic continuity with a new era of leadership Jean-Charles Wirth to become CEO Life Scienc...

February 18, 2025 | Tuesday | News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profi...

February 18, 2025 | Tuesday | Interview
AstraZeneca CEO Pascal Soriot Leads Strong FY 2024 Growth with 21% Revenue Surge and Ambition 2030 in Focus

AstraZeneca delivered $54.1 billion in total revenue for FY 2024, a 21% increase at constant exchange rates (CER), fueled by strong growth across oncolog...

February 07, 2025 | Friday | Company results

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close